PRVA · Privia Health Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $41.47M | - | $39.64M | $37.52M | $31.72M | - | $30.70M | $28.92M | $32.12M | - |
| Total Operating Expenses | $596.42M | - | $566.02M | $517.82M | $474.88M | - | $432.11M | $417.23M | $414.42M | - |
| D&A | $3.28M | - | $2.77M | $2.58M | $1.90M | - | $1.80M | $1.82M | $1.82M | - |
| Operating Income | $7.42M | - | $14.40M | $3.34M | $5.22M | - | $5.81M | $5.10M | $823.0K | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $5.60M | - | $6.87M | $2.46M | $2.10M | - | $4.00M | $3.42M | $751.0K | - |
| Net Income | $3.06M | - | $6.86M | $2.69M | $4.22M | - | $3.54M | $3.47M | $2.98M | - |
| EPS - Basic | $0.02 | - | $0.06 | $0.02 | $0.03 | - | $0.03 | $0.03 | $0.03 | - |
| EPS - Diluted | $0.02 | - | $0.05 | $0.02 | $0.03 | - | $0.03 | $0.03 | $0.02 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $419.52M | $479.69M | $441.35M | $390.13M | $469.33M | $491.15M | $422.00M | $387.35M | $351.14M | $389.51M |
| Accounts Receivable | $513.68M | $400.90M | $499.04M | $443.99M | $388.73M | $316.18M | $408.96M | $370.06M | $346.09M | $290.77M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $10.65M | $7.97M | $10.22M | $9.01M | $7.95M | $9.76M | $6.93M | $9.06M | $6.43M | $7.88M |
| Current Assets | $966.02M | $911.00M | $970.93M | $882.96M | $886.47M | $834.82M | $853.75M | $779.67M | $728.14M | $700.80M |
| Total Assets | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B | $1.14B | $1.15B | $1.08B | $1.03B | $999.90M |
| Current Liabilities | $601.30M | $568.52M | $582.91M | $534.85M | $470.81M | $449.15M | $479.47M | $429.59M | $403.80M | $386.95M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $611.99M | $578.43M | $588.23M | $539.00M | $474.01M | $452.34M | $483.38M | $434.01M | $408.76M | $392.51M |
| Stockholders' Equity | $753.06M | $737.22M | $709.12M | $682.86M | $659.44M | $635.18M | $614.89M | $595.41M | $576.80M | $561.44M |
| Retained Earnings | ($153.25M) | ($156.31M) | ($165.46M) | ($172.32M) | ($175.01M) | ($179.23M) | ($183.63M) | ($187.16M) | ($190.63M) | ($193.61M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($49.47M) | - | - | - | ($24.06M) | - | - | - | ($33.14M) | - |
| Investing Cash Flow | ($26.0K) | - | - | - | $0 | - | - | - | ($5.71M) | - |
| Financing Cash Flow | ($10.67M) | - | - | - | $2.24M | - | - | - | $475.0K | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 64.6% | - | 50.0% | 47.8% | 33.3% | - | 53.1% | 49.7% | 20.1% | - |
| Return on assets | 0.2% | - | 0.5% | 0.2% | 0.4% | - | 0.3% | 0.3% | 0.3% | - |
| Return on equity | 0.4% | - | 1.0% | 0.4% | 0.6% | - | 0.6% | 0.6% | 0.5% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.61 | 1.60 | 1.67 | 1.65 | 1.88 | 1.86 | 1.78 | 1.81 | 1.80 | 1.81 |
| Quick ratio | 1.61 | 1.60 | 1.67 | 1.65 | 1.88 | 1.86 | 1.78 | 1.81 | 1.80 | 1.81 |
| Cash ratio | 0.70 | 0.84 | 0.76 | 0.73 | 1.00 | 1.09 | 0.88 | 0.90 | 0.87 | 1.01 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.88 | 1.86 | 1.91 | 1.86 | 1.79 | 1.79 | 1.86 | 1.81 | 1.79 | 1.78 |
| Liabilities / Assets | 0.43 | 0.42 | 0.44 | 0.42 | 0.40 | 0.40 | 0.42 | 0.40 | 0.40 | 0.39 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 1028.5x | - | 498.0x | 1150.0x | 748.3x | - | 607.0x | 579.3x | 979.5x | - |
| P / B | 3.6x | - | 4.5x | 4.3x | 4.3x | - | 3.7x | 3.7x | 4.2x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | 212.3x | - | 161.1x | 433.2x | 336.9x | - | 245.5x | 258.9x | 793.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 42.2% | - | 147.8% | -34.6% | 534.0% | - | 5.0% | -27.0% | -87.7% | - |
| Net income growth (YoY) | -27.4% | - | 94.1% | -22.5% | 41.4% | - | -37.4% | -52.3% | -59.3% | - |
| EPS growth (YoY) | -33.3% | - | 66.7% | -33.3% | 50.0% | - | -40.0% | -50.0% | -66.7% | - |
| EPS CAGR (3y) | -30.7% | - | 71.0% | - | - | - | - | -20.6% | -30.7% | - |
| EPS CAGR (5y) | -19.7% | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 14.2% | 16.1% | 15.3% | 14.7% | 14.3% | 13.1% | 12.9% | 13.4% | 12.4% | 12.5% |
Peer comparison
Same SIC group: Services-Health Services
Comparing Privia Health Group against the 5 most active filers in the same SIC group.